Who owns AgomAb Therapeutics NV ADR?
- Ticker: AGMB
- CUSIP Number: 00860c102
Tip: Access positions for across all investors
Analyze quarterly positions in AgomAb Therapeutics NV with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of AgomAb Therapeutics NV stock
Who bought or sold AgomAb Therapeutics NV ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.1M | $67M | 0% | Jun 2026 |
|
| Sanofi | 2.8M | $36M | 0% | Jun 2026 |
|
| Redmile Group | 2.7M | $36M | 1650% | Jun 2026 |
|
| Cormorant Asset Management | 2.5M | $32M | 0% | Jun 2026 |
|
| TCG Crossover Management | 2.1M | $27M | 0% | Jun 2026 |
|
| Federated Investors | 1.6M | $21M | 0% | Jun 2026 |
|
| Nantahala Capital Management | 1.6M | $20M | 31% | Jun 2026 |
|
| Casdin Capital | 1.6M | $20M | 0% | Jun 2026 |
|
| Andera Partners | 1.5M | $20M | 0% | Jun 2026 |
|
| FMR | 1.5M | $19M | 0% | Jun 2026 |
|
| Standard Life Aberdeen | 847k | $11M | 20% | Jun 2026 |
|
| Samsara BioCapital | 600k | $7.8M | 0% | Jun 2026 |
|
| Perceptive Advisors | 600k | $7.8M | 0% | Jun 2026 |
|
| Siren | 411k | $5.3M | 0% | Jun 2026 |
|
| OrbiMed Advisors | 193k | $2.5M | 100% | Jun 2026 |
|
| Pfizer | 75k | $1.0M | 0% | Jun 2026 |
|
| ALPS Advisors | 50k | $649k | 100% | Jun 2026 |
|
| Bellevue Group | 49k | $639k | -2% | Jun 2026 |
|
| Seven Grand Managers | 48k | $618k | -76% | Jun 2026 |
|
| Sectoral Asset Management | 44k | $565k | 0% | Jun 2026 |
|
| Burkehill Global Management | 35k | $454k | 0% | Jun 2026 |
|
| Quadrature Capital | 21k | $266k | 100% | Jun 2026 |
|
| Two Sigma Investments | 18k | $235k | 27% | Jun 2026 |
|
| Hrt Financial | 17k | $221k | -28% | Jun 2026 |
|
| Goldman Sachs Group | 12k | $153k | -67% | Jun 2026 |
|
| XTX Topco | 10k | $133k | 100% | Jun 2026 |
|
| Morgan Stanley | 3.0k | $32k | 100% | Mar 2026 |
|
| UBS Group | 2.1k | $28k | -67% | Jun 2026 |
|
| GAMMA Investing | 1.3k | $17k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 754.00 | $9.8k | 100% | Jun 2026 |
|
| Larson Financial Group | 698.00 | $9.1k | 100% | Jun 2026 |
|
| SBI Securities | 2.00 | $26.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 2.00 | $26.000000 | 100% | Jun 2026 |
|
Who sold out of AgomAb Therapeutics NV?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| LMR Partners | Mar 2026 | 300k | $3.1M |
| Millennium Management | Mar 2026 | 95k | $999k |
| Alyeska Investment Group | Mar 2026 | 75k | $787k |
| Laurion Capital Management | Mar 2026 | 50k | $525k |
| Citadel Advisors | Mar 2026 | 35k | $367k |
| D. E. Shaw & Co | Mar 2026 | 15k | $161k |
| Jane Street | Mar 2026 | 13k | $134k |